Bevespi Aerosphere Aerosol, Metered
Product Images NDC 0310-4600

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Bevespi Aerosphere (NDC 0310-4600). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Mean Change from Baseline in FEV1 over Time on Day 14 (MITT Population))

Figure 1 (Mean Change from Baseline in FEV1 over Time on Day 14 (MITT Population))
This data presents the adjusted mean change from baseline in FEV over time (in hours) for various dosages and types of inhalers (GP MDI 18mcg, GP MDI 9mcg, GP MDI 4.6 mcg, GP MDI 24 mcg, GP MDI 1.2 mcg, GP MDI 0.6 mcg, and Placebo).*
FDA Label Image

Figure 2 (Mean Change from Baseline in FEV1 over Time on Day 1)

Figure 2 (Mean Change from Baseline in FEV1 over Time on Day 1)
FDA Label Image

Figure 3 (Mean Change from Baseline in FEV1 over Time at Day 1 and Week 12 (Trial 1) Day 1)

Figure 3 (Mean Change from Baseline in FEV1 over Time at Day 1 and Week 12 (Trial 1) Day 1)
This is a graph displaying the adjusted mean change from baseline in FEV (forced expiratory volume) over time (in hours) for four different treatments: BEVESPI AEROSPHERE, GPMDI 18 mcg, FF MDI 9.6 mcg, and Placebo. The x-axis represents time while the y-axis represents the adjusted mean change in FEV (in 350 g units).*
FDA Label Image

Week 12 (Bevespi Aerosphere 06)

Week 12 (Bevespi Aerosphere 06)
This appears to be a graph displaying the adjusted mean change from baseline in some variable over time (in hours) for four different treatments, including "BEVESPI AEROSPHERE," "GPMDI 18 mcg," "FFMDI 9.6 mcg," and "Placebo." Without additional context or information, it is not possible to determine what the variable being measured is.*
FDA Label Image

Principal Display Panel Ndc 0310-4600-12 Bevespi Aerosphere 9 Mcg/4.8 Mcg Per Inhalation 120 Inhalations For Oral Inhalation Only (Bevespi Aerosphere 1a)

Principal Display Panel Ndc 0310-4600-12 Bevespi Aerosphere 9 Mcg/4.8 Mcg Per Inhalation 120 Inhalations For Oral Inhalation Only (Bevespi Aerosphere 1a)
FDA Label Image

Image 01

Image 01
The text provides a visual representation of a medical device, likely an inhaler, from the side view. The device consists of a canister, an actuator, and a mouthpiece, with a dose indicator also visible. The purpose and details of the device are not provided in the text.*
FDA Label Image

Image 02

Image 02
The text provides a description of Figure 2a, 2b, and 2c showing the number of puffs - 120, 110, and 100 respectively. It is not clear what the figures are related to without further information.*
FDA Label Image

Image 03

Image 03
FDA Label Image

Image 04

Image 04
FDA Label Image

Image 05

Image 05
FDA Label Image

Image 06

Image 06
FDA Label Image

Image 07

Image 07
FDA Label Image

Image 08

Image 08
FDA Label Image

Image 09

Image 09
FDA Label Image

Image 10

Image 10
FDA Label Image

Image 11

Image 11
FDA Label Image

Image 12

Image 12
FDA Label Image

Image 13

Image 13
FDA Label Image

Image 14

Image 14
FDA Label Image

Image 15

Image 15
FDA Label Image

Image 16

Image 16
FDA Label Image

Image 17

Image 17
FDA Label Image

Image 18

Image 18
FDA Label Image

Image 19

Image 19
FDA Label Image

Image 20

Image 20
FDA Label Image

Image 21

Image 21

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.